HomeCompareULIHF vs PLD

ULIHF vs PLD: Dividend Comparison 2026

ULIHF yields 4.61% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ULIHF wins by $3907.88M in total portfolio value
10 years
ULIHF
ULIHF
● Live price
4.61%
Share price
$1.30
Annual div
$0.06
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3914.38M
Annual income
$3,757,849,931.79
Full ULIHF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — ULIHF vs PLD

📍 ULIHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodULIHFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ULIHF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ULIHF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ULIHF
Annual income on $10K today (after 15% tax)
$392.01/yr
After 10yr DRIP, annual income (after tax)
$3,194,172,442.02/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, ULIHF beats the other by $3,189,704,471.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ULIHF + PLD for your $10,000?

ULIHF: 50%PLD: 50%
100% PLD50/50100% ULIHF
Portfolio after 10yr
$1960.44M
Annual income
$1,881,553,183.99/yr
Blended yield
95.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

ULIHF
No analyst data
Altman Z
2.5
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ULIHF buys
0
PLD buys
0
No recent congressional trades found for ULIHF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricULIHFPLD
Forward yield4.61%3.18%
Annual dividend / share$0.06$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%74.4%
Portfolio after 10y$3914.38M$6.50M
Annual income after 10y$3,757,849,931.79$5,256,436.18
Total dividends collected$3903.33M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ULIHF vs PLD ($10,000, DRIP)

YearULIHF PortfolioULIHF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$11,622$922.37$11,255$555.24+$367.00ULIHF
2$14,440$2,003.76$13,062$1,018.59+$1.4KULIHF
3$20,104$4,653.23$15,903$1,926.67+$4.2KULIHF
4$33,620$12,109.28$20,839$3,823.32+$12.8KULIHF
5$73,826$37,852.07$30,464$8,166.08+$43.4KULIHF
6$234,355$155,361.26$52,054$19,457.30+$182.3KULIHF
7$1,172,599$921,838.97$109,886$54,188.93+$1.06MULIHF
8$9,876,061$8,621,381.00$304,030$186,451.18+$9.57MULIHF
9$146,291,644$135,724,258.55$1,166,125$840,813.32+$145.13MULIHF
10$3,914,381,991$3,757,849,931.79$6,504,190$5,256,436.18+$3907.88MULIHF

ULIHF vs PLD: Complete Analysis 2026

ULIHFStock

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.

Full ULIHF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this ULIHF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ULIHF vs SCHDULIHF vs JEPIULIHF vs OULIHF vs KOULIHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.